4.2 Read 56 reviews
Overview
What you will study
Approximately 30% of people with schizophrenia have treatment-resistant schizophrenia (TRS), meaning they have not responded to at least two antipsychotic trials.
Research into TRS is ongoing, with developments in assessment and treatment helping to improve the functional outcomes and quality of life of individuals and their carers.
This Treatment Resistant Schizophrenia course offered by University of Melbourne brings together the latest research and developments in clinical practice to provide health professionals with a comprehensive understanding and up-to-date summary of the epidemiology, assessment and treatment of TRS. For those with an understanding of TRS, it provides a refresher in these key areas.
Programme Structure
The program focuses on:
- What is treatment-resistant schizophrenia
- Epidemiology of treatment-resistant schizophrenia
- Role of clozapine and monitoring requirements
- Clozapine resistance and augmentation
Key information
Duration
- Part-time
- 1 days
Start dates & application deadlines
- StartingApply anytime.
Language
English
Delivered
Online
Disciplines
Clinical Psychology View 4 other Short Courses in Clinical Psychology in AustraliaAcademic requirements
We are not aware of any specific GRE, GMAT or GPA grading score requirements for this programme.
English requirements
We are not aware of any English requirements for this programme.
Other requirements
General requirements
- CRICOS: 00116K
- There are no eligibility requirements.
Tuition Fee
To always see correct tuition fees
-
International
55 AUD/fullTuition FeeBased on the tuition of 55 AUD for the full programme during 1 days. -
National
55 AUD/fullTuition FeeBased on the tuition of 55 AUD for the full programme during 1 days.
Funding
Improve page content